Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Supreme Court (2)
- 10(b) (1)
- Banking and Finance (1)
- Basic (1)
- Congress (1)
-
- Corporations (1)
- Courts (1)
- Disclosure (1)
- Drug Producer (1)
- Economics (1)
- Efficient market (1)
- Fraud (1)
- Fraud on the market (1)
- Halliburton (1)
- Law and Economics (1)
- Litigation (1)
- Materiality (1)
- Patent (1)
- Pharmaceutical (1)
- Price distortion (1)
- Price impact (1)
- Regulation (1)
- Regulatory (1)
- Reliance (1)
- Reverse Payment (1)
- Rule 10b-5 (1)
- SEC (1)
- Securities (1)
- Securities Exchange Act (1)
- Securities Law (1)
- Publication
- Publication Type
Articles 1 - 4 of 4
Full-Text Articles in Securities Law
Inevitable Imbalance: Why Ftc V. Actavis Was Inadequate To Solve The Reverse Payment Settlement Problem And Proposing A New Amendment To The Hatch-Waxman Act, Rachel A. Lewis
Seattle University Law Review
The law regarding reverse payment settlements is anything but settled. Reverse payment settlements are settlements that occur during a patent infringement litigation in which a pharmaceutical patent holder pays a generic drug producer to not infringe on the pharmaceutical patent. Despite the recent decision by the United States Supreme Court in FTC v. Actavis, Inc., there are still unanswered questions about how the “full rule of reason” analysis will be applied to reverse payment. This Comment argues that despite the outcome in Actavis, the complex regulatory framework of the Hatch–Waxman Act will create repeated conflicts between antitrust law and patent …
Halliburton, Basic And Fraud On The Market: The Need For A New Paradigm, Charles W. Murdock
Halliburton, Basic And Fraud On The Market: The Need For A New Paradigm, Charles W. Murdock
Charles W. Murdock
Summary: Halliburton, Basic and Fraud on the Market: The Need for a New Paradigm
If defrauded securities plaintiffs cannot bring a class-action lawsuit, there often will be no effective remedy since the amount at stake for individual plaintiffs is not sufficient to warrant the substantial costs of litigation. To surmount the problem of individualized reliance and establish commonality, federal courts for twenty-five years have been employing the Basic fraud-on-the-market theory which posits that, in an efficient market, investors rely on the integrity of the market price.
While class certification at one time was a matter of course, today it is …
Judgment Day For Fraud-On-The-Market: Reflections On Amgen And The Second Coming Of Halliburton, Donald C. Langevoort
Judgment Day For Fraud-On-The-Market: Reflections On Amgen And The Second Coming Of Halliburton, Donald C. Langevoort
Georgetown Law Faculty Publications and Other Works
The Supreme Court has reaffirmed the "fraud on the market" presumption of reliance, facilitating large scale class actions for this kind of securities fraud. This essay traces the road from its decision last year in Amgen to this year's reaffirmation in Halliburton II, and considers some of the issues that will emerge as lower courts struggle with Halliburton II's secondary holding--that the issue of "price impact" is crucial to class certification, even if the burden of proof is on the defendants.
Taking Section 10(B) Seriously: Criminal Enforcement Of Sec Rules, Steve Thel
Taking Section 10(B) Seriously: Criminal Enforcement Of Sec Rules, Steve Thel
Faculty Scholarship
The Supreme Court has determined the scope of federal securities laws in a series of cases in which it has read section 10(b) of the Securities Exchange Act as either prohibiting certain misconduct or authorizing the SEC to regulate that conduct and only that conduct. Judging by the language, structure and history of the Exchange Act, the Court’s reading is wrong. Section 10(b) does not prohibit anything, and it neither grants the SEC rulemaking power nor limits the rulemaking power granted to the SEC elsewhere in the Exchange Act. Instead, section 10(b) simply triggers criminal sanctions for certain rule violations. …